Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.

Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S.

Arthritis Rheum. 2006 Sep;54(9):2757-64. Erratum in: Arthritis Rheum. 2006 Oct;54(10):3134.

3.

[Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice].

La Montagna G, Tirri R, Vitello R, Malesci D, Buono R, Mennillo G, Valentini G.

Reumatismo. 2006 Oct-Dec;58(4):261-7. Italian.

4.

The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.

Finckh A, Dehler S, Gabay C; SCQM doctors.

Ann Rheum Dis. 2009 Jan;68(1):33-9. doi: 10.1136/ard.2007.085696. Epub 2008 Jan 29.

PMID:
18230627
5.
6.

Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.

Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J, Paulus HE, Xia HA, Leff JA; RADIUS Investigators.

Curr Med Res Opin. 2006 Jan;22(1):185-98.

PMID:
16393444
7.

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis.

Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH.

Arthritis Rheum. 2007 Jun;56(6):1754-64.

8.

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.

Strangfeld A, Hierse F, Rau R, Burmester GR, Krummel-Lorenz B, Demary W, Listing J, Zink A.

Arthritis Res Ther. 2010;12(1):R5. doi: 10.1186/ar2904. Epub 2010 Jan 8.

9.

Therapeutic strategies in rheumatoid arthritis over a 40-year period.

Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE.

J Rheumatol. 2004 Dec;31(12):2366-73.

PMID:
15570636
10.

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.

Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, Levin R, Solomon DH.

Arthritis Rheum. 2007 Aug 15;57(6):928-34.

11.
12.
13.
14.
15.

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2007 Sep;56(9):2905-12.

16.

Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.

Cannon GW, Holden WL, Juhaeri J, Dai W, Scarazzini L, Stang P.

J Rheumatol. 2004 Oct;31(10):1906-11.

PMID:
15468352
17.

Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.

Galindo-Rodriguez G, Aviña-Zubieta JA, Russell AS, Suarez-Almazor ME.

J Rheumatol. 1999 Nov;26(11):2337-43.

PMID:
10555887
18.

Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis.

Grijalva CG, Chung CP, Arbogast PG, Stein CM, Mitchel EF Jr, Griffin MR.

Med Care. 2007 Oct;45(10 Supl 2):S66-76.

PMID:
17909386
19.

The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.

Wu CY, Chen DY, Shen JL, Ho HJ, Chen CC, Kuo KN, Liu HN, Chang YT, Chen YJ.

Arthritis Res Ther. 2014 Sep 30;16(5):449. doi: 10.1186/s13075-014-0449-5. Erratum in: Arthritis Res Ther. 2016;18(1):110.

20.

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L, Feltelius N.

Ann Rheum Dis. 2005 Oct;64(10):1414-20. Epub 2005 Apr 20.

Items per page

Supplemental Content

Write to the Help Desk